Proliferation of progeria cells is enhanced by lamina-associated polypeptide 2α (LAP2α) through expression of extracellular matrix proteins

Genes and Development

Volumn 29, Issue 19, 2015, Pages 2022-2036

  Vidak, Sandra ^a   Kubben, Nard ^b   Dechat, Thomas ^a   Foisner, Rol ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

A type lamins; Cell proliferation regulation; Extracellular matrix; Hutchinson Gilford progeria; Lamina associated polypeptide; Nuclear lamina; Nucleoplasmic lamins

Indexed keywords

LAMIN A; LAMIN C; LAMINA ASSOCIATED POLYPEPTIDE 2ALPHA; POLYPEPTIDE; SCLEROPROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; LAMINA-ASSOCIATED POLYPEPTIDE 2; LMNA PROTEIN, HUMAN; MEMBRANE PROTEIN; PRELAMIN A;

ARTICLE; CELL PROLIFERATION; DOWN REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; NUCLEAR LAMINA; PRIORITY JOURNAL; PROGERIA; PROTEIN EXPRESSION; UPREGULATION; CELL CULTURE; CELL LINE; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LAMIN TYPE A; MEMBRANE PROTEINS; PROGERIA; UP-REGULATION;

EID: 84943572682     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.263939.115     Document Type: Article

References (59)

1. Brachner A, Foisner R. 2011. Evolvement ofLEMproteins as chromatin tethers at the nuclear periphery. Biochem Soc Trans 39: 1735-1741.
2. Brachner A, Foisner R. 2014. Lamina-associated polypeptide (LAP)2α and other LEM proteins in cancer biology. Adv Exp Med Biol 773: 143-163.
3. Bridger JM, Kill IR. 2004. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol 39: 717-724.
4. Burtner CR, Kennedy BK. 2010. Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol 11: 567-578.
5. Cai M, Huang Y, Ghirlando R, Wilson KL, Craigie R, Clore GM. 2001. Solution structure of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one binds BAF and the other binds DNA. EMBO J 20: 4399-4407.
6. Cao K, Capell BC, Erdos MR, Djabali K, Collins FS. 2007. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells. Proc Natl Acad Sci 104: 4949-4954.
7. Cao K, Graziotto JJ, Blair CD, Mazzulli JR, Erdos MR, Krainc D, Collins FS. 2011. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Science Transl Med 3: 89ra58.
8. Cenni V, Capanni C, Columbaro M, Ortolani M, D'Apice MR, Novelli G, Fini M, Marmiroli S, Scarano E, Maraldi NM, et al. 2011. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria. Eur J Histochem 55: e36.
9. Cseh B, Fernandez-Sauze S, Grall D, Schaub S, Doma E, Van Obberghen-Schilling E. 2010. Autocrine fibronectin directs matrix assembly and crosstalk between cell-matrix and cell-cell adhesion in vascular endothelial cells. J Cell Sci 123: 3989-3999.
10. Csoka AB, English SB, Simkevich CP, Ginzinger DG, Butte AJ, Schatten GP, Rothman FG, Sedivy JM. 2004. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell 3: 235-243.
11. Dahl KN, Scaffidi P, Islam MF, Yodh AG, Wilson KL, Misteli T. 2006. Distinct structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci 103: 10271-10276.
12. Dechat T, Gotzmann J, Stockinger A, Harris CA, Talle MA, Siekierka JJ, Foisner R. 1998. Detergent-salt resistance of LAP2α in interphase nuclei and phosphorylation-dependent association with chromosomes early in nuclear assembly implies functions in nuclear structure dynamics. EMBO J 17: 4887-4902.
13. Dechat T, Korbei B, Vaughan OA, Vlcek S, Hutchison CJ, Foisner R. 2000. Lamina-associated polypeptide 2α binds intranuclear A-type lamins. J Cell Sci 113: 3473-3484.
14. Dechat T, Gajewski A, Korbei B, Gerlich D, Daigle N, Haraguchi T, Furukawa K, Ellenberg J, Foisner R. 2004. LAP2α and BAF transiently localize to telomeres and specific regions on chromatin during nuclear assembly. J Cell Sci 117: 6117-6128.
15. Dechat T, Shimi T, Adam SA, Rusinol AE, Andres DA, Spielmann HP, Sinensky MS, Goldman RD. 2007. Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging. Proc Natl Acad Sci 104: 4955-4960.
16. Dechat T, Adam SA, Taimen P, Shimi T, Goldman RD. 2010a. Nuclear lamins. Cold Spring Harb Perspect Biol 2: a000547.
17. Dechat T, Gesson K, Foisner R. 2010b. Lamina-independent lamins in the nuclear interior serve important functions. Cold Spring Harb Symp Quant Biol 75: 533-543.
18. de la Rosa J, Freije JM, Cabanillas R, Osorio FG, FragaMF, Fernandez- Garcia MS, Rad R, Fanjul V, Ugalde AP, Liang Q, et al. 2013. PrelaminAcauses progeria through cell-extrinsic mechanisms and prevents cancer invasion. Nat Commun 4: 2268.
19. Delbarre E, Tramier M, Coppey-Moisan M, Gaillard C, Courvalin JC, Buendia B. 2006. The truncated prelaminAin Hutchinson- Gilford progeria syndrome alters segregation of A-type and Btype lamin homopolymers. Hum Mol Genet 15: 1113-1122.
20. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, et al. 2003. LaminA truncation in Hutchinson-Gilford progeria. Science 300: 2055.
21. Dorner D, Vlcek S, Foeger N, Gajewski A, MakolmC, Gotzmann J, Hutchison CJ, Foisner R. 2006. Lamina-associated polypeptide 2α regulates cell cycle progression and differentiation via the retinoblastoma-E2F pathway. J Cell Biol 173: 83-93.
22. Eriksson M, BrownWT, Gordon LB, GlynnMW, Singer J, Scott L, Erdos MR, Robbins CM, MosesTY, Berglund P, et al. 2003. Recurrent de novo point mutations in lamin A cause Hutchinson- Gilford progeria syndrome. Nature 423: 293-298.
23. Espada J, Varela I, Flores I, Ugalde AP, Cadinanos J, Pendas AM, Stewart CL, Tryggvason K, Blasco MA, Freije JM, et al. 2008. Nuclear envelope defects cause stem cell dysfunction in premature- aging mice. J Cell Biol 181: 27-35.
24. Gesson K, Vidak S, Foisner R. 2014. Lamina-associated polypeptide (LAP)2α and nucleoplasmic lamins in adult stem cell regulation and disease. Semin Cell Dev Biol 29: 116-124.
25. Ghosh S, Zhou Z. 2014. Genetics of aging, progeria and lamin disorders. Curr Opin Genet Dev 26: 41-46.
26. Gordon LB, Rothman FG, Lopez-Otin C, Misteli T. 2014. Progeria: a paradigm for translational medicine. Cell 156: 400-407.
27. Gotic I, Schmidt WM, Biadasiewicz K, Leschnik M, Spilka R, Braun J, Stewart CL, Foisner R. 2010. Loss of LAP2α delays satellite cell differentiation and affects postnatal fiber-type determination. Stem Cells 28: 480-488.
28. Gruenbaum Y, Foisner R. 2015. Lamins: nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation. Annu Rev Biochem 84: 131-164.
29. Hauser C, Schuettengruber B, Bartl S, Lagger G, Seiser C. 2002. Activation of the mouse histone deacetylase 1 gene by cooperative histone phosphorylation and acetylation. Mol Cell Biol 22: 7820-7830.
30. Hernandez L, Roux KJ, Wong ES, Mounkes LC, Mutalif R, Navasankari R, Rai B, Cool S, Jeong JW, Wang H, et al. 2010. Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev Cell 19: 413-425.
31. Kind J, Pagie L, Ortabozkoyun H, Boyle S, de Vries SS, Janssen H, Amendola M, Nolen LD, BickmoreWA, van Steensel B. 2013. Single-cell dynamics of genome-nuclear lamina interactions. Cell 153: 178-192.
32. Kochin V, Shimi T, Torvaldson E, Adam SA, Goldman A, Pack CG, Melo-Cardenas J, Imanishi SY, Goldman RD, Eriksson JE. 2014. Interphase phosphorylation of lamin A. J Cell Sci 127: 2683-2696.
33. Kolb T, Maass K, Hergt M, Aebi U, Herrmann H. 2011. Lamin A and lamin C form homodimers and coexist in higher complex forms both in the nucleoplasmic fraction and in the lamina of cultured human cells. Nucleus 2: 425-433.
34. Lund E, Oldenburg AR, Delbarre E, Freberg CT, Duband-Goulet I, Eskeland R, Buendia B, Collas P. 2013. Lamin A/C-promoter interactions specify chromatin state-dependent transcription outcomes. Genome Res 23: 1580-1589.
35. Marji J,O'Donoghue SI, McClintock D, Satagopam VP, Schneider R, Ratner D, Worman HJ, Gordon LB, Djabali K. 2010. Defective lamin A-Rb signaling in Hutchinson-Gilford progeria syndrome and reversal by farnesyltransferase inhibition. PLoS One 5: e11132.
36. Markiewicz E, Dechat T, Foisner R, Quinlan RA, Hutchison CJ. 2002. Lamin A/C binding protein LAP2α is required for nuclear anchorage of retinoblastoma protein. Mol Biol Cell 13: 4401-4413.
37. Markiewicz E, Ledran M, Hutchison CJ. 2005. Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro. J Cell Sci 118: 409- 420.
38. McClintock D, Gordon LB, Djabali K. 2006. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci 103: 2154-2159.
39. McCord RP, Nazario-Toole A, Zhang H, Chines PS, Zhan Y, Erdos MR, Collins FS, Dekker J, Cao K. 2013. Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome. Genome Res 23: 260-269.
40. Moir RD, Yoon M, Khuon S, Goldman RD. 2000. Nuclear laminsAand B1: different pathways of assembly during nuclear envelope formation in living cells. J Cell Biol 151: 1155-1168.
41. Naetar N, Foisner R. 2009. Lamin complexes in the nuclear interior control progenitor cell proliferation and tissue homeostasis. Cell Cycle 8: 1488-1493.
42. Naetar N, Hutter S, Dorner D, Dechat T, Korbei B, Gotzmann J, Beug H, Foisner R. 2007. LAP2α-binding protein LINT-25 is a novel chromatin-associated protein involved in cell cycle exit. J Cell Sci 120: 737-747.
43. Naetar N, Korbei B, Kozlov S, Kerenyi MA, Dorner D, Kral R, Gotic I, Fuchs P, Cohen TV, Bittner R, et al. 2008. Loss of nucleoplasmic LAP2α-lamin A complexes causes erythroid and epidermal progenitor hyperproliferation. Nat Cell Biol 10: 1341-1348.
44. Osmanagic-Myers S, Dechat T, Foisner R. 2015. Lamins at the crossroads of mechanosignaling. Genes Dev 29: 225-237.
45. Parise P, Finocchiaro G, Masciadri B, Quarto M, Francois S, Mancuso F, Muller H. 2006. Lap2α expression is controlled by E2F and deregulated in various human tumors. Cell Cycle 5: 1331-1341.
46. Pekovic V, Harborth J, Broers JL, Ramaekers FC, van Engelen B, Lammens M, von Zglinicki T, Foisner R, Hutchison C, Markiewicz E. 2007. Nucleoplasmic LAP2α-lamin A complexes are required to maintain a proliferative state in human fibroblasts. J Cell Biol 176: 163-172.
47. Pendas AM, Zhou Z, Cadinanos J, Freije JM,Wang J, Hultenby K, Astudillo A, Wernerson A, Rodriguez F, Tryggvason K, et al. 2002. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31: 94-99.
48. Pilat U, Dechat T, Bertrand AT,Woisetschlager N, Gotic I, Spilka R, Biadasiewicz K, Bonne G, Foisner R. 2013. The muscle dystrophy- causing ΔK32 lamin A/C mutant does not impair the functions of the nucleoplasmic lamin-A/C-LAP2α complex in mice. J Cell Sci 126: 1753-1762.
49. Roblek M, Schüchner S, Huber V, Ollram K, Vlcek-Vesely S, Foisner R,Wehnert M, Ogris E. 2010. Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W. PLoS One 5: e10604.
50. Rusinol AE, Sinensky MS. 2006. Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors. J Cell Sci 119: 3265-3272.
51. Scaffidi P, Misteli T. 2005. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med 11: 440-445.
52. Scaffidi P, Misteli T. 2006. Lamin A-dependent nuclear defects in human aging. Science 312: 1059-1063.
53. Scaffidi P, Misteli T. 2008. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 10: 452-459.
54. Shumaker DK, Dechat T, Kohlmaier A, Adam SA, Bozovsky MR, Erdos MR, Eriksson M, Goldman AE, Khuon S, Collins FS, et al. 2006. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc Natl Acad Sci 103: 8703-8708.
55. Vlcek S, Just H, Dechat T, Foisner R. 1999. Functional diversity of LAP2α and LAP2β in postmitotic chromosome association is caused by an α-specific nuclear targeting domain. EMBO J 18: 6370-6384.
56. Vlcek S, Korbei B, Foisner R. 2002. Distinct functions of the unique C terminus of LAP2α in cell proliferation and nuclear assembly. J Biol Chem 277: 18898-18907.
57. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
58. ZhangJ,LianQ,ZhuG,ZhouF,SuiL,TanC,MutalifRA,Navasankari R, Zhang Y, Tse H-F, et al. 2011. A human iPSC model of Hutchinson Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8: 31-45.
59. Zhang S, Schones DE, Malicet C, Rochman M, Zhou M, Foisner R, Bustin M. 2013. High mobility group protein N5 (HMGN5) and lamina-associated polypeptide 2α (LAP2α) interact and reciprocally affect their genome-wide chromatin organization. J Biol Chem 288: 18104-18109.